Legacy Foresees PE Scrutiny, Bets Big on AI to Ease Nursing Home Reimbursement and Regulatory Pressures
You are unauthorized to view this page. Username Password Remember Me Forgot Password
Q2
Legacy Foresees PE Scrutiny, Bets Big on AI to Ease Nursing Home Reimbursement and Regulatory Pressures
Legacy Healthcare’s near-term growth strategy is centered around fine-tuning internal systems and processes to adjust for the ‘constant battle’ of the two Rs – reimbursement and regulation. And so, amid expectations of tighter scrutiny on private equity investment and legislation that could squeeze margins, the organization is betting big on AI to alleviate the operational
Martis Capital, Healthcare-Focused PE Firm, Acquires Majority Stake in Healthcare Marketing, Communications, and Media Agency Deerfield Group
Martis Capital Management, LLC (Martis Capital), a private equity firm focused exclusively on the middle market healthcare industry, today announced it has acquired a majority equity stake in Deerfield Group, a leading marketing, communications, and media partner for the healthcare and life sciences sectors. Deerfield Group, based in the Philadelphia area, has increased revenue by
Martis Capital, Healthcare-Focused PE Firm, Acquires Majority Stake in Healthcare Marketing, Communications, and Media Agency Deerfield Group
You are unauthorized to view this page.
Cathay Capital Invests in Ascendia Autism Care to Expand Access to Evidence-Based ABA Therapy for Children and Families
Cathay Capital announced the launch of Ascendia Autism Care, a new platform dedicated to expanding access to evidence-based Applied Behavior Analysis (ABA) therapy for children with autism spectrum disorder and their families. Ascendia begins operations with a founding affiliate that operates 20 centers across eight states, with plans for continued growth through de novo expansion
Corten and Ampersand Complete Acquisition of Beacon Intelligence to Accelerate Growth in Life Sciences R&D Intelligence
Corten Capital and Ampersand Capital Partners (“Ampersand”) are pleased to announce the completion of their acquisition of Beacon Intelligence (“Beacon” or the “Company”) from the Hanson Wade Group, backed by Graphite Capital. Ampersand is investing alongside Corten as a minority co-investor in the transaction. Beacon was founded in 2015 within the Hanson Wade Group, an
Headlands Research Expands California Presence with Acquisition of Clinical Trials Research
Headlands Research, a leading clinical trial site network, announces the acquisition of Clinical Trials Research (CTR), a privately owned clinical research organization with locations in Sacramento and Lincoln, California. The sites will operate as Headlands Research – Sacramento and Headlands Research – CTR Lincoln. CTR has conducted more than 300 Phase I-IV clinical trials with